These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 36592548)
1. Esomeprazole induces structural changes and apoptosis and alters function of in vitro canine neoplastic mast cells. Gould EN; Szule JA; Wilson-Robles H; Steiner JM; Lennon EM; Tolbert MK Vet Immunol Immunopathol; 2023 Feb; 256():110539. PubMed ID: 36592548 [TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs. Kuhl A; Odunayo A; Price J; Hecht S; Marshall K; Steiner J; Tolbert MK J Vet Intern Med; 2020 Mar; 34(2):678-683. PubMed ID: 32020689 [TBL] [Abstract][Full Text] [Related]
3. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms. Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958 [TBL] [Abstract][Full Text] [Related]
4. In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells. Gamperl S; Stefanzl G; Willmann M; Valent P; Hadzijusufovic E Vet Med Sci; 2021 Jan; 7(1):57-68. PubMed ID: 32924324 [TBL] [Abstract][Full Text] [Related]
5. Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells. Gamperl S; Stefanzl G; Peter B; Smiljkovic D; Bauer K; Willmann M; Valent P; Hadzijusufovic E Vet Comp Oncol; 2019 Dec; 17(4):553-561. PubMed ID: 31286638 [TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of the effect of acid suppressant drugs on leukocyte ratios in dogs with mast cell tumors. Oberholtzer S; Zhu X; Dedeaux A; Martin O; Gould EN J Vet Intern Med; 2024; 38(4):2305-2315. PubMed ID: 38888250 [TBL] [Abstract][Full Text] [Related]
7. Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability. D'Costa S; Ayyadurai S; Gibson AJ; Mackey E; Rajput M; Sommerville LJ; Wilson N; Li Y; Kubat E; Kumar A; Subramanian H; Bhargava A; Moeser AJ J Allergy Clin Immunol; 2019 May; 143(5):1865-1877.e4. PubMed ID: 30439403 [TBL] [Abstract][Full Text] [Related]
8. H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells. Hadzijusufovic E; Peter B; Gleixner KV; Schuch K; Pickl WF; Thaiwong T; Yuzbasiyan-Gurkan V; Mirkina I; Willmann M; Valent P Exp Hematol; 2010 Oct; 38(10):896-907. PubMed ID: 20570632 [TBL] [Abstract][Full Text] [Related]
9. Esomeprazole reduces sperm motility index by targeting the spermic cholinergic machinery: A mechanistic study for the association between use of proton pump inhibitors and reduced sperm motility index. Kumar A; Kumar R; Flanagan J; Långström B; Björndahl L; Darreh-Shori T Biochem Pharmacol; 2020 Dec; 182():114212. PubMed ID: 32866455 [TBL] [Abstract][Full Text] [Related]
10. Characterizing the inhibitory action of zinc oxide nanoparticles on allergic-type mast cell activation. Feltis BN; Elbaz A; Wright PF; Mackay GA; Turney TW; Lopata AL Mol Immunol; 2015 Aug; 66(2):139-46. PubMed ID: 25771180 [TBL] [Abstract][Full Text] [Related]
11. Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3. Narumi K; Sato Y; Kobayashi M; Furugen A; Kasashi K; Yamada T; Teshima T; Iseki K Biopharm Drug Dispos; 2017 Dec; 38(9):501-508. PubMed ID: 28801980 [TBL] [Abstract][Full Text] [Related]
12. WZ3146 inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses in vitro and in vivo. Park YH; Kim DK; Kim HS; Lee D; Lee MB; Min KY; Jo MG; Lee JE; Kim YM; Choi WS Toxicol Appl Pharmacol; 2019 Nov; 383():114763. PubMed ID: 31526816 [TBL] [Abstract][Full Text] [Related]
13. Frontline Science: Corticotropin-releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress-induced pathophysiology. Ayyadurai S; Gibson AJ; D'Costa S; Overman EL; Sommerville LJ; Poopal AC; Mackey E; Li Y; Moeser AJ J Leukoc Biol; 2017 Dec; 102(6):1299-1312. PubMed ID: 28684600 [TBL] [Abstract][Full Text] [Related]
14. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study). Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1/Egr1/IL-4 axis. Wang HN; Ji K; Zhang LN; Xie CC; Li WY; Zhao ZF; Chen JJ J Transl Med; 2021 Jun; 19(1):261. PubMed ID: 34130714 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. Fenger JM; Bear MD; Volinia S; Lin TY; Harrington BK; London CA; Kisseberth WC BMC Cancer; 2014 Feb; 14():84. PubMed ID: 24517413 [TBL] [Abstract][Full Text] [Related]
17. Short-term in vitro culture of purity and highly functional rat bone marrow-derived mast cells. Yu T; Liu B; He Z; Yang M; Song J; Ma C; Ma S; Feng J; Wang X; Li J In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):705-714. PubMed ID: 30341632 [TBL] [Abstract][Full Text] [Related]
18. The antipsychotic drug pimozide inhibits IgE-mediated mast cell degranulation and migration. Hou YB; Zhang LN; Wang HN; Zhao ZF; Sun YT; Ji K; Chen JJ Int Immunopharmacol; 2020 Jul; 84():106500. PubMed ID: 32311669 [TBL] [Abstract][Full Text] [Related]
19. Does β-hexosaminidase function only as a degranulation indicator in mast cells? The primary role of β-hexosaminidase in mast cell granules. Fukuishi N; Murakami S; Ohno A; Yamanaka N; Matsui N; Fukutsuji K; Yamada S; Itoh K; Akagi M J Immunol; 2014 Aug; 193(4):1886-94. PubMed ID: 25015817 [TBL] [Abstract][Full Text] [Related]
20. Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment. Colucci R; Fornai M; Antonioli L; Ghisu N; Tuccori M; Blandizzi C; Del Tacca M Dig Liver Dis; 2009 Jun; 41(6):395-405. PubMed ID: 19251492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]